Paper20847201
Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study.
Iannaccone CK and 8 others. Rheumatology (Oxford), 2011. Cited by 87 papers, by iCite.
Cite this record
ConductScience Library. Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study. Papers, record 20847201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20847201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antirheumatic Agents | Major topic |
| Arthritis, Rheumatoid | Major topic |
| Genetic Predisposition to Disease | Major topic |
| Tumor Necrosis Factor-alpha | Major topic |
| Biomarkers | |
| Cohort Studies | |
| Female | |
| Humans | |
| Middle Aged | |
| Registries | |
| Severity of Illness Index | |
| Surveys and Questionnaires | |
| Treatment Outcome |
Source PubMed
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42014144 | Associations between achieving treatment targets and functional and economic outcomes in patients with rheumatoid arthritis: retrospective cohort analyses of BRASS registry data. | BMJ Open | 2026 | https://conductscience.org/library/papers/42014144 | PubMed |
| 41972843 | Inferring Rheumatoid Arthritis Disease Activity Status From the Electronic Health Records Across Health Systems. | Arthritis Rheumatol | 2026 | https://conductscience.org/library/papers/41972843 | PubMed |
| 41757188 | Biomarkers for Atherosclerotic Cardiovascular Events in Rheumatoid Arthritis: Towards Validation of a Biomarker-Enhanced Risk Model. | medRxiv | 2026 | https://conductscience.org/library/papers/41757188 | PubMed |
| 41245987 | Comparison of PREVENT with the pooled cohort equation for estimating atherosclerotic cardiovascular disease risk among patients with rheumatoid arthritis. | Am J Prev Cardiol | 2025 | https://conductscience.org/library/papers/41245987 | PubMed |
| 40362255 | Genetic Variants of the ATIC Gene and Therapeutic Response to Methotrexate in Patients with Rheumatoid Arthritis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362255 | PubMed |
| 39562277 | Artificial intelligence as an assistant for studying treatment response in rheumatoid arthritis. | Semin Arthritis Rheum | 2025 | https://conductscience.org/library/papers/39562277 | PubMed |
| 38898318 | Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease. | Clin Rheumatol | 2024 | https://conductscience.org/library/papers/38898318 | PubMed |
| 37556424 | Refractory inflammatory arthritis definition and model generated through patient and multi-disciplinary professional modified Delphi process. | PLoS One | 2023 | https://conductscience.org/library/papers/37556424 | PubMed |
| 37269020 | Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis. | Arthritis Res Ther | 2023 | https://conductscience.org/library/papers/37269020 | PubMed |
| 37237405 | Association of hemoglobin levels with radiographic progression in patients with rheumatoid arthritis: an analysis from the BRASS registry. | Arthritis Res Ther | 2023 | https://conductscience.org/library/papers/37237405 | PubMed |
| 36874209 | Autoantibodies against citrullinated and native proteins and prediction of rheumatoid arthritis-associated interstitial lung disease: A nested case-control study. | Lancet Rheumatol | 2023 | https://conductscience.org/library/papers/36874209 | PubMed |
| 36009355 | Gene Ontology Analysis Highlights Biological Processes Influencing Non-Response to Anti-TNF Therapy in Rheumatoid Arthritis. | Biomedicines | 2022 | https://conductscience.org/library/papers/36009355 | PubMed |
| 35831345 | Genetic variations in methotrexate metabolic pathway genes influence methotrexate responses in rheumatoid arthritis patients in Malaysia. | Sci Rep | 2022 | https://conductscience.org/library/papers/35831345 | PubMed |
| 35738804 | Meaning of patient global assessment when joint counts are low in rheumatoid arthritis. | RMD Open | 2022 | https://conductscience.org/library/papers/35738804 | PubMed |
| 35497687 | The Prevalence of Pharmacogenomics Variants and Their Clinical Relevance Among the Pakistani Population. | Evol Bioinform Online | 2022 | https://conductscience.org/library/papers/35497687 | PubMed |
| 34875040 | Screening for preclinical parenchymal lung disease in rheumatoid arthritis. | Rheumatology (Oxford) | 2022 | https://conductscience.org/library/papers/34875040 | PubMed |
| 33615723 | Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation. | Arthritis Rheumatol | 2021 | https://conductscience.org/library/papers/33615723 | PubMed |
| 33191286 | Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease. | J Rheumatol | 2021 | https://conductscience.org/library/papers/33191286 | PubMed |
| 33059295 | Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: Prevalence, risk factors, and impact on mortality. | Semin Arthritis Rheum | 2020 | https://conductscience.org/library/papers/33059295 | PubMed |
| 33002337 | Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study Registry. | Arthritis Care Res (Hoboken) | 2021 | https://conductscience.org/library/papers/33002337 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATIC | 471 | PubTator's text mining | https://conductscience.org/library/genes/471 | NCBI Gene |
| CEBPD | 1052 | PubTator's text mining | https://conductscience.org/library/genes/1052 | NCBI Gene |
| PTPRC | 5788 | PubTator's text mining | https://conductscience.org/library/genes/5788 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20847201
GET https://conductscience.org/api/papers/v1/20847201/cited_by?page=2